Insilico Medicine signs co-development collaboration agreement with Hygtia Therapeutics

HistoIndex partners Houston Research Institute

GSK agrees to acquire RAPT Therapeutics to strengthen food allergy pipeline

Alcami acquires RTP facility in Durham, NC

Akeso secures NMPA review acceptance for gumokimab in ankylosing spondylitis

EMA validates Daiichi Sankyo's ENHERTU plus pertuzumab application for first-line HER2 positive metastatic breast cancer

Immunovia gains California approval for PancreaSure and begins commercial rollout

Profusa launches Lumee tissue oxygen system for CRO market

Zylox-Tonbridge agrees staged acquisition of Germany's Optimed

European Commission approves Sobi's Aspaveli for rare kidney diseases

Frontage Laboratories commences GMP facility operations

Myqorzo and Redemplo receive regulatory approval in China

AVEO Oncology reports first patient dosed in front-line AML combination study of ficlatuzumab

GenomOncology and OHSU Knight Diagnostics Lab partner to enhance clinical trial matching for cancer patients

Alfasigma SpA collaborates with Innovative Molecules GmbH on potential treatment for HSV encephalitis